AI in pediatric cancer prediction is revolutionizing how healthcare professionals assess the risk of relapse in young patients suffering from brain tumors.A recent study by researchers at Mass General Brigham has showcased the superior accuracy of artificial intelligence tools over traditional methods in forecasting the likelihood of glioma recurrence.